$17.35 -0.37 (-2.09%)
2/10/2012 4:01 PM

Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Featured Broker Partners


Advertisement